Jason Brittain

About Mr. Brittain

VP of Drug Manufacturing

Jason Brittain has over 25 years of experience with pharmaceutical product development specializing in formulation development and manufacturing of clinical supplies from pre-clinical through commercialization. Throughout his career, Mr. Brittain managed CMC operational activities and strategies for drug substance development/manufacturing, formulation/drug product manufacturing, analytical development/qualification, and labeling / packaging. Mr. Brittain developed and assisted with 10 ANDA parenteral products, the formulator of Treanda® and LIVMARLI®, and the lead small molecule filing of the Japanese approval of Akalux®. Mr. Brittain assisted with multiple CMC technical due diligences for in-licensing and partnering activities throughout his career.